Our results highlight the importance of the PNPLA3 genotype and FIB-4 index ≥ 2.67 on the incidence of complications in Japanese patients with NAFLD, especially the incidence of CVDs. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.